chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 93.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test negative, SARS-CoV-2 test positive
Clinical narrative: COVID infection following COVID vaccine series 01/13 COVID vaccine dose#1 02/04 COVID vaccine dose #2 09/30 Pre-procedure COVID test positive, remained asymptomatic 10/21 COVID vaccine dose #3
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: Hypoaesthesia oral
Clinical narrative: ADR documented as tongue swelling/throat swelling, however notes from time of incident note only tongue numbness and patient explicitly denied tongue swelling or throat swelling. Patient did not get second dose of vaccine due to possible allergic reaction.
Age: 52.0
Sex: M
Vaccine: COVID19
Symptoms: Swelling
Clinical narrative: Patient reported swelling of left side of his neck, noted to be same side as injection. Not noted if reoccurred with second vaccination.
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: COVID infection following COVID vaccine series 01/27, Moderna , dose #1 02/25, Moderna , dose #2 11/13 COVID swab, result: detected 11/13 pt cc: asymptotic exposure: unknown
Age: 64.0
Sex: M
Vaccine: VARZOS
Symptoms: Unevaluable event
Clinical narrative: Narrative:
Age: 98.0
Sex: M
Vaccine: FLU4
Symptoms: Chronic obstructive pulmonary disease, Dyspnoea, Pyrexia
Clinical narrative: Narrative:  Pt had fever of 102 degrees F 2-3 hours after influenza vaccine, and shortness of breath. Pt was taken to the hospital pneumonia was ruled out. His diagnosis was felt to be "COPD exacerbation" -- Team decided in the futre ot should have regular influenza vaccine not high dose influenza vaccine
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Exposure to SARS-CoV-2, SARS-CoV-2 test positive
Clinical narrative: COVIND infection following COVID vaccine series 01/19, Pfizer, dose #1 02/09, Pfizer, dose #2 11/15 COVID swab, result: detected 11/06 pt cc: Rhinorrhea exposure: unknown
Age: 34.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Chest X-ray normal, Cough, Pyrexia, SARS-CoV-2 test positive
Clinical narrative: COVID infection following COVID vaccine series 04/12, Pfizer, dose #1 05/03, Pfizer, dose #2 09/21 COVID-19 ANTIGEN BINAX result: not detected 09/21 COVID-19 MONT result: not detected 11/17 pt cc: cough, fever exposure: unknown 11/17 CXR impression : No acute disease is seen. Of note, plain radiography is insensitive for the detection of subtle groundglass as can be seen in viral infection. 11/17 COVID swab, result: detected 11/17 SARS-COV-2 Variant Sequencing result: pending 11/26 COVID swab, result: detected
Age: 34.0
Sex: M
Vaccine: COVID19
Symptoms: Viral infection
Clinical narrative: COVID infection following COVID vaccine series 04/12, Pfizer, dose #1 05/03, Pfizer, dose #2 09/21 COVID-19 ANTIGEN BINAX result: not detected 09/21 COVID-19 MONT result: not detected 11/17 pt cc: cough, fever exposure: unknown 11/17 CXR impression : No acute disease is seen. Of note, plain radiography is insensitive for the detection of subtle groundglass as can be seen in viral infection. 11/17 COVID swab, result: detected 11/17 SARS-COV-2 Variant Sequencing result: pending 11/26 COVID swab, result: detected
Age: 61.0
Sex: M
Vaccine: COVID19
Symptoms: Adrenal mass, Angiogram, Atelectasis, Blood fibrinogen increased, COVID-19
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 04/12, Moderna , dose #2 11/17 pt admit medicine cc: confusion dx: LOS: 11/17 CXR impression: Stable small right pleural effusion with increased right basilar opacity which may represent associated atelectasis or pneumonia. 11/17 pt cc: exposure: unknown 11/17 COVID swab, result: detected 11/18 COVID swab, result: NOT detected 11/18 CTA PE impression: No pulmonary embolus. Small right pleural effusion with right basilar consolidation, likely compressive atelectasis. Left adrenal gland 3 cm nodule of indeterminate density. Consider comparison to prior outside imaging if available. Alternatively, recommend non urgent CT adrenal protocol. 11/19 FIBRINOGEN: 529 11/19 DDIMER: 1.34 11/19 ESR: 80 11/19 US DOPPLER impression: Bilateral lower extremity: patency and compressibility of the visualized portion of the deep venous system without evidence for thrombosis. Spectral waveform analysis: normal phasic flow and appropriate response to augmentation. Venous structures identified and cleared: Common femoral vein, femoral vein, and popliteal vein. No popliteal fossa cysts identified.Bland
Age: 61.0
Sex: M
Vaccine: COVID19
Symptoms: Chest X-ray abnormal, Confusional state, Fibrin D dimer increased, Lung consolidation, Lung opacity
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 04/12, Moderna , dose #2 11/17 pt admit medicine cc: confusion dx: LOS: 11/17 CXR impression: Stable small right pleural effusion with increased right basilar opacity which may represent associated atelectasis or pneumonia. 11/17 pt cc: exposure: unknown 11/17 COVID swab, result: detected 11/18 COVID swab, result: NOT detected 11/18 CTA PE impression: No pulmonary embolus. Small right pleural effusion with right basilar consolidation, likely compressive atelectasis. Left adrenal gland 3 cm nodule of indeterminate density. Consider comparison to prior outside imaging if available. Alternatively, recommend non urgent CT adrenal protocol. 11/19 FIBRINOGEN: 529 11/19 DDIMER: 1.34 11/19 ESR: 80 11/19 US DOPPLER impression: Bilateral lower extremity: patency and compressibility of the visualized portion of the deep venous system without evidence for thrombosis. Spectral waveform analysis: normal phasic flow and appropriate response to augmentation. Venous structures identified and cleared: Common femoral vein, femoral vein, and popliteal vein. No popliteal fossa cysts identified.Bland
Age: 61.0
Sex: M
Vaccine: COVID19
Symptoms: Pleural effusion, Red blood cell sedimentation rate increased, SARS-CoV-2 test positive, Ultrasound Doppler normal
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 04/12, Moderna , dose #2 11/17 pt admit medicine cc: confusion dx: LOS: 11/17 CXR impression: Stable small right pleural effusion with increased right basilar opacity which may represent associated atelectasis or pneumonia. 11/17 pt cc: exposure: unknown 11/17 COVID swab, result: detected 11/18 COVID swab, result: NOT detected 11/18 CTA PE impression: No pulmonary embolus. Small right pleural effusion with right basilar consolidation, likely compressive atelectasis. Left adrenal gland 3 cm nodule of indeterminate density. Consider comparison to prior outside imaging if available. Alternatively, recommend non urgent CT adrenal protocol. 11/19 FIBRINOGEN: 529 11/19 DDIMER: 1.34 11/19 ESR: 80 11/19 US DOPPLER impression: Bilateral lower extremity: patency and compressibility of the visualized portion of the deep venous system without evidence for thrombosis. Spectral waveform analysis: normal phasic flow and appropriate response to augmentation. Venous structures identified and cleared: Common femoral vein, femoral vein, and popliteal vein. No popliteal fossa cysts identified.Bland
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Ageusia, Anosmia, COVID-19, Chest X-ray abnormal, Dyspnoea
Clinical narrative: COVID infection following COVID vaccine series 01/28, Pfizer, dose #1 02/19, Pfizer, dose #2 11/08 pt cc: fatigue, headache, loss of taste or smell, myalgias, rhinorrhea, dyspnea exposure: unknown 11/18 COVID swab, result: detected 11/23 SARS-COV-2 Variant Sequencing result: pending 11/29 CXR impression: 1. Lung hyperinflation likely secondary to air trapping again noted, otherwise, no radiographic evidence of acute cardiopulmonary disease. 2. Nonspecific bowl gas pattern.
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Headache, Lung hyperinflation, Myalgia, Rhinorrhoea
Clinical narrative: COVID infection following COVID vaccine series 01/28, Pfizer, dose #1 02/19, Pfizer, dose #2 11/08 pt cc: fatigue, headache, loss of taste or smell, myalgias, rhinorrhea, dyspnea exposure: unknown 11/18 COVID swab, result: detected 11/23 SARS-COV-2 Variant Sequencing result: pending 11/29 CXR impression: 1. Lung hyperinflation likely secondary to air trapping again noted, otherwise, no radiographic evidence of acute cardiopulmonary disease. 2. Nonspecific bowl gas pattern.
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive
Clinical narrative: COVID infection following COVID vaccine series 01/28, Pfizer, dose #1 02/19, Pfizer, dose #2 11/08 pt cc: fatigue, headache, loss of taste or smell, myalgias, rhinorrhea, dyspnea exposure: unknown 11/18 COVID swab, result: detected 11/23 SARS-COV-2 Variant Sequencing result: pending 11/29 CXR impression: 1. Lung hyperinflation likely secondary to air trapping again noted, otherwise, no radiographic evidence of acute cardiopulmonary disease. 2. Nonspecific bowl gas pattern.
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Unevaluable event
Clinical narrative: Narrative: None stated.
Age: 82.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Headache, Injection site pain, Nausea, Vomiting
Clinical narrative: Patient reported headache, nausea, joint pain, vomiting, and injection site pain 1 day after getting 3rd/booster dose of moderna, subsided on it's own after~2 days. Did not report similar reaction with initial 2 dose series.
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Narrative: COVID infection following COVID vaccines series No prior COVID-19 immunization on record 11/17 COVID swab, result: detected 10/23 pt cc: coughing, wheezing, fever, fatigue exposure: unknown 11/19 clinically resolved
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Unevaluable event
Clinical narrative: Narrative: None stated.
Age: 39.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Cough, Exposure to SARS-CoV-2, SARS-CoV-2 test positive
Clinical narrative: Narrative: COVID infection following COVID vaccine series 04/01, Pfizer, dose #1 04/22, Pfizer, dose #2 11/12 pt cc: cough, exposure: unknown 11/17 COVID swab, result: detected 11/22 clinically resolved
Age: 85.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Acute kidney injury, Blood creatinine increased, Blood gases abnormal, COVID-19, COVID-19 pneumonia
Clinical narrative: Narrative:  Admission Date: Nov 19,2021 Discharge Date: Nov 21,2021 Condition of patient at discharge: Stable Disposition of Patient at Discharge: Home Primary Diagnosis during Admission/Treatment: COVID PNA Secondary Diagnosis(es)during Admission/Treatment: 85 yo male PMH HTN, HPL, CAD s/p multi-vessel, CABG in 2010, aortic bioprosthetic valve replacement in 2010, BPI brought to Emergency Department (ED) for malaise and not doing well at home per EMS. Patient himself is unclear why he is here and family was not able to be contacted for collateral information. Per patient, he stated that his wife thinks that he had been getting more confused recently. Unclear how much more confused this was from his baseline. Patient denied having any shortness of breath or having a hard time breathing, however he did note that he was diagnosed with COVID the previous week (test result unavailable). Patient does not usually require oxygen when at home. He also stated that in the last week he had been having some episodes of diarrhea, however he denied any nausea or vomiting. He denied any fevers, chills, or chest pain as well. He noted that he had a rash on his legs that had been there for awhile, however he did not note to have any pain in his legs. When patient arrived to the ED he was unaccompanied by any family and he was unsure why he was specifically in the ED. He was afebrile and hemodynamically stable. Patient was reportedly desatting to the high 80s on R/ A and was placed on 2L NC. CBC and BMP were largely unremarkable although did have an AKI w/ Cr of 2.15 (BL 1.8-1.9). Cardiac workup insignificant as well. VBG obtained showed a decreased O2. Patient also had a ferritin of 2527 and d-dimer mildly elevated to 1.64. COVID test was positive (despite double vaccination with Pfizer COVID vaccine on 2/1/2021 and 2/22/2021. Patient had CXR notable for airspace disease consistent with COVID and possible superimposed Pneumonia. Given concern for superimposed pneumonia patient received azithromycin and cerftriaxone and was given 1L NS bolus. Brief Summary of Hospital Course: #Covid PNA: Patient required 2L in the ED and does not require O2 at home. Currently COVID positive on 11/19/21 with first COVID positive on 11/9/21. CXR in ED w/ superimposed Pneumonia (PNA), though unconvincing radiographically - symptomatically, patient with no elevated white count, no sputum production, afebrile. Procal 0.14. Initially started on ceftriaxone/azithro, discontinued as evidence more for COVID PNA than bacterial. Initially started dexamethasone 6mh daily due to increased O2 requirement, however patient weaned and stable in room air x 24 hours, discontinued dexamethasone at that time. Patient passed walk test (O2 sat above 90-92 with ambulation) and stable for discharge home. #AKI, improved: Cr 2.15 on admission with baseline around 1.8-1.9. Patient endorses not being as hydrated as normal. S/p 1L NS bolus in Ed. Creatinine downtrended to 1.63 without intervention, back to baseline.
Age: 85.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Cardiac assistance device user, Cardiac function test abnormal, Cardiomegaly, Chest X-ray abnormal, Confusional state
Clinical narrative: Narrative:  Admission Date: Nov 19,2021 Discharge Date: Nov 21,2021 Condition of patient at discharge: Stable Disposition of Patient at Discharge: Home Primary Diagnosis during Admission/Treatment: COVID PNA Secondary Diagnosis(es)during Admission/Treatment: 85 yo male PMH HTN, HPL, CAD s/p multi-vessel, CABG in 2010, aortic bioprosthetic valve replacement in 2010, BPI brought to Emergency Department (ED) for malaise and not doing well at home per EMS. Patient himself is unclear why he is here and family was not able to be contacted for collateral information. Per patient, he stated that his wife thinks that he had been getting more confused recently. Unclear how much more confused this was from his baseline. Patient denied having any shortness of breath or having a hard time breathing, however he did note that he was diagnosed with COVID the previous week (test result unavailable). Patient does not usually require oxygen when at home. He also stated that in the last week he had been having some episodes of diarrhea, however he denied any nausea or vomiting. He denied any fevers, chills, or chest pain as well. He noted that he had a rash on his legs that had been there for awhile, however he did not note to have any pain in his legs. When patient arrived to the ED he was unaccompanied by any family and he was unsure why he was specifically in the ED. He was afebrile and hemodynamically stable. Patient was reportedly desatting to the high 80s on R/ A and was placed on 2L NC. CBC and BMP were largely unremarkable although did have an AKI w/ Cr of 2.15 (BL 1.8-1.9). Cardiac workup insignificant as well. VBG obtained showed a decreased O2. Patient also had a ferritin of 2527 and d-dimer mildly elevated to 1.64. COVID test was positive (despite double vaccination with Pfizer COVID vaccine on 2/1/2021 and 2/22/2021. Patient had CXR notable for airspace disease consistent with COVID and possible superimposed Pneumonia. Given concern for superimposed pneumonia patient received azithromycin and cerftriaxone and was given 1L NS bolus. Brief Summary of Hospital Course: #Covid PNA: Patient required 2L in the ED and does not require O2 at home. Currently COVID positive on 11/19/21 with first COVID positive on 11/9/21. CXR in ED w/ superimposed Pneumonia (PNA), though unconvincing radiographically - symptomatically, patient with no elevated white count, no sputum production, afebrile. Procal 0.14. Initially started on ceftriaxone/azithro, discontinued as evidence more for COVID PNA than bacterial. Initially started dexamethasone 6mh daily due to increased O2 requirement, however patient weaned and stable in room air x 24 hours, discontinued dexamethasone at that time. Patient passed walk test (O2 sat above 90-92 with ambulation) and stable for discharge home. #AKI, improved: Cr 2.15 on admission with baseline around 1.8-1.9. Patient endorses not being as hydrated as normal. S/p 1L NS bolus in Ed. Creatinine downtrended to 1.63 without intervention, back to baseline.
Age: 85.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Dehydration, Diarrhoea, Fibrin D dimer increased, Full blood count normal, Lung opacity
Clinical narrative: Narrative:  Admission Date: Nov 19,2021 Discharge Date: Nov 21,2021 Condition of patient at discharge: Stable Disposition of Patient at Discharge: Home Primary Diagnosis during Admission/Treatment: COVID PNA Secondary Diagnosis(es)during Admission/Treatment: 85 yo male PMH HTN, HPL, CAD s/p multi-vessel, CABG in 2010, aortic bioprosthetic valve replacement in 2010, BPI brought to Emergency Department (ED) for malaise and not doing well at home per EMS. Patient himself is unclear why he is here and family was not able to be contacted for collateral information. Per patient, he stated that his wife thinks that he had been getting more confused recently. Unclear how much more confused this was from his baseline. Patient denied having any shortness of breath or having a hard time breathing, however he did note that he was diagnosed with COVID the previous week (test result unavailable). Patient does not usually require oxygen when at home. He also stated that in the last week he had been having some episodes of diarrhea, however he denied any nausea or vomiting. He denied any fevers, chills, or chest pain as well. He noted that he had a rash on his legs that had been there for awhile, however he did not note to have any pain in his legs. When patient arrived to the ED he was unaccompanied by any family and he was unsure why he was specifically in the ED. He was afebrile and hemodynamically stable. Patient was reportedly desatting to the high 80s on R/ A and was placed on 2L NC. CBC and BMP were largely unremarkable although did have an AKI w/ Cr of 2.15 (BL 1.8-1.9). Cardiac workup insignificant as well. VBG obtained showed a decreased O2. Patient also had a ferritin of 2527 and d-dimer mildly elevated to 1.64. COVID test was positive (despite double vaccination with Pfizer COVID vaccine on 2/1/2021 and 2/22/2021. Patient had CXR notable for airspace disease consistent with COVID and possible superimposed Pneumonia. Given concern for superimposed pneumonia patient received azithromycin and cerftriaxone and was given 1L NS bolus. Brief Summary of Hospital Course: #Covid PNA: Patient required 2L in the ED and does not require O2 at home. Currently COVID positive on 11/19/21 with first COVID positive on 11/9/21. CXR in ED w/ superimposed Pneumonia (PNA), though unconvincing radiographically - symptomatically, patient with no elevated white count, no sputum production, afebrile. Procal 0.14. Initially started on ceftriaxone/azithro, discontinued as evidence more for COVID PNA than bacterial. Initially started dexamethasone 6mh daily due to increased O2 requirement, however patient weaned and stable in room air x 24 hours, discontinued dexamethasone at that time. Patient passed walk test (O2 sat above 90-92 with ambulation) and stable for discharge home. #AKI, improved: Cr 2.15 on admission with baseline around 1.8-1.9. Patient endorses not being as hydrated as normal. S/p 1L NS bolus in Ed. Creatinine downtrended to 1.63 without intervention, back to baseline.
Age: 85.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Malaise, Metabolic function test normal, Oxygen saturation decreased, Procalcitonin, Rash
Clinical narrative: Narrative:  Admission Date: Nov 19,2021 Discharge Date: Nov 21,2021 Condition of patient at discharge: Stable Disposition of Patient at Discharge: Home Primary Diagnosis during Admission/Treatment: COVID PNA Secondary Diagnosis(es)during Admission/Treatment: 85 yo male PMH HTN, HPL, CAD s/p multi-vessel, CABG in 2010, aortic bioprosthetic valve replacement in 2010, BPI brought to Emergency Department (ED) for malaise and not doing well at home per EMS. Patient himself is unclear why he is here and family was not able to be contacted for collateral information. Per patient, he stated that his wife thinks that he had been getting more confused recently. Unclear how much more confused this was from his baseline. Patient denied having any shortness of breath or having a hard time breathing, however he did note that he was diagnosed with COVID the previous week (test result unavailable). Patient does not usually require oxygen when at home. He also stated that in the last week he had been having some episodes of diarrhea, however he denied any nausea or vomiting. He denied any fevers, chills, or chest pain as well. He noted that he had a rash on his legs that had been there for awhile, however he did not note to have any pain in his legs. When patient arrived to the ED he was unaccompanied by any family and he was unsure why he was specifically in the ED. He was afebrile and hemodynamically stable. Patient was reportedly desatting to the high 80s on R/ A and was placed on 2L NC. CBC and BMP were largely unremarkable although did have an AKI w/ Cr of 2.15 (BL 1.8-1.9). Cardiac workup insignificant as well. VBG obtained showed a decreased O2. Patient also had a ferritin of 2527 and d-dimer mildly elevated to 1.64. COVID test was positive (despite double vaccination with Pfizer COVID vaccine on 2/1/2021 and 2/22/2021. Patient had CXR notable for airspace disease consistent with COVID and possible superimposed Pneumonia. Given concern for superimposed pneumonia patient received azithromycin and cerftriaxone and was given 1L NS bolus. Brief Summary of Hospital Course: #Covid PNA: Patient required 2L in the ED and does not require O2 at home. Currently COVID positive on 11/19/21 with first COVID positive on 11/9/21. CXR in ED w/ superimposed Pneumonia (PNA), though unconvincing radiographically - symptomatically, patient with no elevated white count, no sputum production, afebrile. Procal 0.14. Initially started on ceftriaxone/azithro, discontinued as evidence more for COVID PNA than bacterial. Initially started dexamethasone 6mh daily due to increased O2 requirement, however patient weaned and stable in room air x 24 hours, discontinued dexamethasone at that time. Patient passed walk test (O2 sat above 90-92 with ambulation) and stable for discharge home. #AKI, improved: Cr 2.15 on admission with baseline around 1.8-1.9. Patient endorses not being as hydrated as normal. S/p 1L NS bolus in Ed. Creatinine downtrended to 1.63 without intervention, back to baseline.
Age: 85.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: SARS-CoV-2 test positive, Serum ferritin increased, White blood cell count normal
Clinical narrative: Narrative:  Admission Date: Nov 19,2021 Discharge Date: Nov 21,2021 Condition of patient at discharge: Stable Disposition of Patient at Discharge: Home Primary Diagnosis during Admission/Treatment: COVID PNA Secondary Diagnosis(es)during Admission/Treatment: 85 yo male PMH HTN, HPL, CAD s/p multi-vessel, CABG in 2010, aortic bioprosthetic valve replacement in 2010, BPI brought to Emergency Department (ED) for malaise and not doing well at home per EMS. Patient himself is unclear why he is here and family was not able to be contacted for collateral information. Per patient, he stated that his wife thinks that he had been getting more confused recently. Unclear how much more confused this was from his baseline. Patient denied having any shortness of breath or having a hard time breathing, however he did note that he was diagnosed with COVID the previous week (test result unavailable). Patient does not usually require oxygen when at home. He also stated that in the last week he had been having some episodes of diarrhea, however he denied any nausea or vomiting. He denied any fevers, chills, or chest pain as well. He noted that he had a rash on his legs that had been there for awhile, however he did not note to have any pain in his legs. When patient arrived to the ED he was unaccompanied by any family and he was unsure why he was specifically in the ED. He was afebrile and hemodynamically stable. Patient was reportedly desatting to the high 80s on R/ A and was placed on 2L NC. CBC and BMP were largely unremarkable although did have an AKI w/ Cr of 2.15 (BL 1.8-1.9). Cardiac workup insignificant as well. VBG obtained showed a decreased O2. Patient also had a ferritin of 2527 and d-dimer mildly elevated to 1.64. COVID test was positive (despite double vaccination with Pfizer COVID vaccine on 2/1/2021 and 2/22/2021. Patient had CXR notable for airspace disease consistent with COVID and possible superimposed Pneumonia. Given concern for superimposed pneumonia patient received azithromycin and cerftriaxone and was given 1L NS bolus. Brief Summary of Hospital Course: #Covid PNA: Patient required 2L in the ED and does not require O2 at home. Currently COVID positive on 11/19/21 with first COVID positive on 11/9/21. CXR in ED w/ superimposed Pneumonia (PNA), though unconvincing radiographically - symptomatically, patient with no elevated white count, no sputum production, afebrile. Procal 0.14. Initially started on ceftriaxone/azithro, discontinued as evidence more for COVID PNA than bacterial. Initially started dexamethasone 6mh daily due to increased O2 requirement, however patient weaned and stable in room air x 24 hours, discontinued dexamethasone at that time. Patient passed walk test (O2 sat above 90-92 with ambulation) and stable for discharge home. #AKI, improved: Cr 2.15 on admission with baseline around 1.8-1.9. Patient endorses not being as hydrated as normal. S/p 1L NS bolus in Ed. Creatinine downtrended to 1.63 without intervention, back to baseline.
Age: 40.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Angiogram pulmonary abnormal, Chest X-ray, Differential white blood cell count, Electrocardiogram, Fibrin D dimer
Clinical narrative: I received my Pfizer booster on 20Nov2021. The following Saturday I started to have chest pain on my left side whenever I would take a deep breath. On Sunday the pain increased so I went to the ER. They performed a CT scan and found multiple blood clots in both lungs, worse on the right side. Follow up with PCP on 29Nov2021 and he stated that there no risk factors indicating blood clots from previous labs performed over the past 3 years.
Age: 40.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Full blood count, Painful respiration, Prohormone brain natriuretic peptide, Prothrombin time, Pulmonary embolism
Clinical narrative: I received my Pfizer booster on 20Nov2021. The following Saturday I started to have chest pain on my left side whenever I would take a deep breath. On Sunday the pain increased so I went to the ER. They performed a CT scan and found multiple blood clots in both lungs, worse on the right side. Follow up with PCP on 29Nov2021 and he stated that there no risk factors indicating blood clots from previous labs performed over the past 3 years.
Age: 40.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Scan with contrast abnormal, Troponin
Clinical narrative: I received my Pfizer booster on 20Nov2021. The following Saturday I started to have chest pain on my left side whenever I would take a deep breath. On Sunday the pain increased so I went to the ER. They performed a CT scan and found multiple blood clots in both lungs, worse on the right side. Follow up with PCP on 29Nov2021 and he stated that there no risk factors indicating blood clots from previous labs performed over the past 3 years.
Age: 40.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Angiogram pulmonary abnormal, Chest X-ray abnormal, Chest pain, Electrocardiogram, Painful respiration
Clinical narrative: I received my Pfizer booster on 20Nov2021. The following Saturday I started to have chest pain on my left side whenever I would take a deep breath. On Sunday the pain increased so I went to the ER. They performed a CT scan and found multiple blood clots in both lungs, worse on the right side. Follow up with PCP on 29Nov2021 and he stated that there no risk factors indicating blood clots from previous labs performed over the past 3 years.
Age: 40.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Pulmonary thrombosis, Scan with contrast abnormal
Clinical narrative: I received my Pfizer booster on 20Nov2021. The following Saturday I started to have chest pain on my left side whenever I would take a deep breath. On Sunday the pain increased so I went to the ER. They performed a CT scan and found multiple blood clots in both lungs, worse on the right side. Follow up with PCP on 29Nov2021 and he stated that there no risk factors indicating blood clots from previous labs performed over the past 3 years.
Age: 15.0
Sex: M
Vaccine: COVID19
Symptoms: Product preparation issue
Clinical narrative: reconstitution was incorrect. .8mLinstead of 1.8mL.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site pain, Injection site swelling, Injection site warmth
Clinical narrative: Patient had pain and swelling at injection site. was warm and painful.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Antinuclear antibody, Arthralgia, Discomfort, Full blood count, Metabolic function test
Clinical narrative: The day following the vaccine the pt developed severe arthralgias and myalgias which have persisted.  The severity has decreased, but the pt still requires Ibuprofen for her discomfort/pain
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Pain, Red blood cell sedimentation rate, Rheumatoid factor, Urine analysis
Clinical narrative: The day following the vaccine the pt developed severe arthralgias and myalgias which have persisted.  The severity has decreased, but the pt still requires Ibuprofen for her discomfort/pain
Age: 83.0
Sex: U
Vaccine: COVID19
Symptoms: Chills, Fatigue, Hallucination
Clinical narrative: Severe fatigue, hallucinations, chills per PT.
Age: 13.0
Sex: F
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: Vaccine was given 1 week too early.
Age: 81.0
Sex: F
Vaccine: COVID19
Symptoms: Blood test normal, Diplopia, Feeling abnormal, Vision blurred
Clinical narrative: Double vision, unable to focus: brain fog Checked for stroke at urgent care on Nov 2, 2021, eyes examined by optometrist on Nov 3, 2021, and by opthalmologist on Nov 4, 2021 No stroke, no abnormalities of the eye Able to focus at distance by the second day after shot and each day after improved until 14 days later could focus fairly well, still blurry, worse when tired. Brain fog still present when tired.
Age: 9.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal discomfort, Dizziness, Pallor, Tremor
Clinical narrative: Within minutes of recieving the vaccine pt had an upset stomach felt light headed turned pale and was shaking
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Death
Clinical narrative: Narrative:  73yo male died on 8/4/2021. He had received covid-19 vaccinations on 3/21/21 & 4/11/21. Pt did not receive care, medications or vaccines from medical facility. No information available regarding pt's death. Likely not related to pt's death given length of time from vaccine administration.
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Acute respiratory failure, Anticoagulant therapy, COVID-19, COVID-19 pneumonia, Death
Clinical narrative: Narrative:  65y.o. MALE with a h/o sleep apnea/narcolepsy, HTN, obesity, Gout, Vitamin D deficiency, BPH, arthritis, and T2DM presented to ER on 8/11/21 with SOB. Pt tested positive for covid-19. Pt had previously been vaccinated with covid-19 pfizer on 3/5/21 & 3/26/21 from facility (outside provider). Pt was intubated due to hypoxia and admitted to MICU. Pt was treated with covid medications (tocilizumab & remdesivir), antibiotics, corticosteroids, and anticoagulants. Pt died on 8/17/2021. Death was caused by: Acute hypoxic respiratory failure and septic shock secondary to COVID pneumonia and suspected secondary bacterial pneumonia and Staph aureus bacteremia.
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Dyspnoea, Endotracheal intubation, Hypoxia, Intensive care, Pneumonia bacterial
Clinical narrative: Narrative:  65y.o. MALE with a h/o sleep apnea/narcolepsy, HTN, obesity, Gout, Vitamin D deficiency, BPH, arthritis, and T2DM presented to ER on 8/11/21 with SOB. Pt tested positive for covid-19. Pt had previously been vaccinated with covid-19 pfizer on 3/5/21 & 3/26/21 from facility (outside provider). Pt was intubated due to hypoxia and admitted to MICU. Pt was treated with covid medications (tocilizumab & remdesivir), antibiotics, corticosteroids, and anticoagulants. Pt died on 8/17/2021. Death was caused by: Acute hypoxic respiratory failure and septic shock secondary to COVID pneumonia and suspected secondary bacterial pneumonia and Staph aureus bacteremia.
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive, Septic shock, Staphylococcal bacteraemia
Clinical narrative: Narrative:  65y.o. MALE with a h/o sleep apnea/narcolepsy, HTN, obesity, Gout, Vitamin D deficiency, BPH, arthritis, and T2DM presented to ER on 8/11/21 with SOB. Pt tested positive for covid-19. Pt had previously been vaccinated with covid-19 pfizer on 3/5/21 & 3/26/21 from facility (outside provider). Pt was intubated due to hypoxia and admitted to MICU. Pt was treated with covid medications (tocilizumab & remdesivir), antibiotics, corticosteroids, and anticoagulants. Pt died on 8/17/2021. Death was caused by: Acute hypoxic respiratory failure and septic shock secondary to COVID pneumonia and suspected secondary bacterial pneumonia and Staph aureus bacteremia.
Age: 44.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: COVID-19, COVID-19 pneumonia, Cardiogenic shock, Death, SARS-CoV-2 test positive
Clinical narrative: Narrative:  Patient received two doses of Pfizer COVID 19 vaccine in April 2021. The patient tested positive for COVID 19 on 5 August 2021. The patient was hospitalized with COVID pneumonia on 17 Aug 21. The patient died due to septic and cardiogenic shock due from COVID pneumonia. The EUA requires that any patient that receives the vaccine and is diagnosed with COVID 19 that results in hospitalization or death must be reported.
Age: 44.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Septic shock
Clinical narrative: Narrative:  Patient received two doses of Pfizer COVID 19 vaccine in April 2021. The patient tested positive for COVID 19 on 5 August 2021. The patient was hospitalized with COVID pneumonia on 17 Aug 21. The patient died due to septic and cardiogenic shock due from COVID pneumonia. The EUA requires that any patient that receives the vaccine and is diagnosed with COVID 19 that results in hospitalization or death must be reported.
Age: 90.0
Sex: M
Vaccine: COVID19
Symptoms: Death
Clinical narrative: Narrative: 89-year-old male with a h/o HTN, HLD, leukemia 2017, A.Fib, depression, anxiety, CAD s/p CABG and bioprosthetic aortic valve replacement in 11/04, mitral valve clip, bladder cancer s/p CTX, cardiac stents x 2, AAA repair, bilateral carotid endarterectomy, lung nodules died on 8/4/2021. Pt had received covid vaccinations on 1/12/2021 & 4/1/2021. This death is likely not related to the vaccinations due to other comorbidities, age, and length of time from vaccine administration.
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Acute kidney injury, Asthenia, COVID-19, COVID-19 pneumonia, Chest pain
Clinical narrative: Narrative:  Patient hospitalized x 2 for care related to COVID-19 pneumonia. Admitted 7/31/21 following presentation with c/o 1 week of nonproductive cough, congestion, weakness, mild shortness of breath and diarrhea. Poor appetite and not eating well but no nausea or vomiting. Given IV fluids, IV remdesivir, oxygen, dexamethasone. Dexamethasone worsened hyperglycemia and as patient felt better was held. At discharge - all diarrhea resolved, felt better, appetite improved, able to walk 100 ft without oxygen. Discharged 8/4/21. Readmitted 8/9/21 after presenting with progressing weakness and shortness of breath, new onset chest pain and continued loss of appetite. On admission, afebrile, BP 95/60, 92% O2 saturation on room air with anion gap lactic acidosis. He was resuscitated with 3L IVF and acidosis and AKI resolved. Appetite and oral intake improved with appropriate urine output and bowel movements. Discharged home 8/12/21.
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Cough, Decreased appetite, Diarrhoea, Dyspnoea, Hyperglycaemia
Clinical narrative: Narrative:  Patient hospitalized x 2 for care related to COVID-19 pneumonia. Admitted 7/31/21 following presentation with c/o 1 week of nonproductive cough, congestion, weakness, mild shortness of breath and diarrhea. Poor appetite and not eating well but no nausea or vomiting. Given IV fluids, IV remdesivir, oxygen, dexamethasone. Dexamethasone worsened hyperglycemia and as patient felt better was held. At discharge - all diarrhea resolved, felt better, appetite improved, able to walk 100 ft without oxygen. Discharged 8/4/21. Readmitted 8/9/21 after presenting with progressing weakness and shortness of breath, new onset chest pain and continued loss of appetite. On admission, afebrile, BP 95/60, 92% O2 saturation on room air with anion gap lactic acidosis. He was resuscitated with 3L IVF and acidosis and AKI resolved. Appetite and oral intake improved with appropriate urine output and bowel movements. Discharged home 8/12/21.
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Hypophagia, Lactic acidosis, Metabolic acidosis, Respiratory tract congestion, SARS-CoV-2 test positive
Clinical narrative: Narrative:  Patient hospitalized x 2 for care related to COVID-19 pneumonia. Admitted 7/31/21 following presentation with c/o 1 week of nonproductive cough, congestion, weakness, mild shortness of breath and diarrhea. Poor appetite and not eating well but no nausea or vomiting. Given IV fluids, IV remdesivir, oxygen, dexamethasone. Dexamethasone worsened hyperglycemia and as patient felt better was held. At discharge - all diarrhea resolved, felt better, appetite improved, able to walk 100 ft without oxygen. Discharged 8/4/21. Readmitted 8/9/21 after presenting with progressing weakness and shortness of breath, new onset chest pain and continued loss of appetite. On admission, afebrile, BP 95/60, 92% O2 saturation on room air with anion gap lactic acidosis. He was resuscitated with 3L IVF and acidosis and AKI resolved. Appetite and oral intake improved with appropriate urine output and bowel movements. Discharged home 8/12/21.
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Urine output, Walking distance test normal
Clinical narrative: Narrative:  Patient hospitalized x 2 for care related to COVID-19 pneumonia. Admitted 7/31/21 following presentation with c/o 1 week of nonproductive cough, congestion, weakness, mild shortness of breath and diarrhea. Poor appetite and not eating well but no nausea or vomiting. Given IV fluids, IV remdesivir, oxygen, dexamethasone. Dexamethasone worsened hyperglycemia and as patient felt better was held. At discharge - all diarrhea resolved, felt better, appetite improved, able to walk 100 ft without oxygen. Discharged 8/4/21. Readmitted 8/9/21 after presenting with progressing weakness and shortness of breath, new onset chest pain and continued loss of appetite. On admission, afebrile, BP 95/60, 92% O2 saturation on room air with anion gap lactic acidosis. He was resuscitated with 3L IVF and acidosis and AKI resolved. Appetite and oral intake improved with appropriate urine output and bowel movements. Discharged home 8/12/21.
Age: 76.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Atrial fibrillation, COVID-19, COVID-19 pneumonia, Cough, Dizziness
Clinical narrative: Narrative:  Completed Pfizer 2 dose COVID19 vaccination on 2/25/21. Presented to ER on 7/18/21 with one day of lightheadedness and cough. New onset afib and COVID + test. Patient declined hospital admission and was d/c the same day. Patient presented to ER again on 7/24/21 due to continued fever, myalgias, and "generally feeling bad". O2 saturation dropped to 88% and troponins were slightly elevated. Diagnosed with COVID pneumonia Admitted with supplemental O2 and dexamethasone 6mg daily initiated. COVID supportive care and oxygen provided during hospitalization. Discharged 8/2/21 with guaifenesin, benzonatate, and methylprednisolone dose pack. Multiple comorbidities including CHF, cardiac defibrillator/pacemaker placement DM, PVD, CAD, MI, ESRD on hemodialysis, obesity, COPD, and microvascular DM complications.
Age: 76.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Feeling abnormal, Myalgia, Oxygen saturation decreased, Pyrexia, SARS-CoV-2 test positive
Clinical narrative: Narrative:  Completed Pfizer 2 dose COVID19 vaccination on 2/25/21. Presented to ER on 7/18/21 with one day of lightheadedness and cough. New onset afib and COVID + test. Patient declined hospital admission and was d/c the same day. Patient presented to ER again on 7/24/21 due to continued fever, myalgias, and "generally feeling bad". O2 saturation dropped to 88% and troponins were slightly elevated. Diagnosed with COVID pneumonia Admitted with supplemental O2 and dexamethasone 6mg daily initiated. COVID supportive care and oxygen provided during hospitalization. Discharged 8/2/21 with guaifenesin, benzonatate, and methylprednisolone dose pack. Multiple comorbidities including CHF, cardiac defibrillator/pacemaker placement DM, PVD, CAD, MI, ESRD on hemodialysis, obesity, COPD, and microvascular DM complications.
Age: 76.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Troponin increased
Clinical narrative: Narrative:  Completed Pfizer 2 dose COVID19 vaccination on 2/25/21. Presented to ER on 7/18/21 with one day of lightheadedness and cough. New onset afib and COVID + test. Patient declined hospital admission and was d/c the same day. Patient presented to ER again on 7/24/21 due to continued fever, myalgias, and "generally feeling bad". O2 saturation dropped to 88% and troponins were slightly elevated. Diagnosed with COVID pneumonia Admitted with supplemental O2 and dexamethasone 6mg daily initiated. COVID supportive care and oxygen provided during hospitalization. Discharged 8/2/21 with guaifenesin, benzonatate, and methylprednisolone dose pack. Multiple comorbidities including CHF, cardiac defibrillator/pacemaker placement DM, PVD, CAD, MI, ESRD on hemodialysis, obesity, COPD, and microvascular DM complications.
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Narrative: Breakthrough COVID-19 confirmed by outside lab in fully vaccinated patient.
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: Parkinson's disease
Clinical narrative: Narrative: patient was on hospice for end stage Parkinson's disease
Age: 75.0
Sex: M
Vaccine: VARZOS
Symptoms: Blister, Burning sensation, Rash, Rash pruritic
Clinical narrative: Narrative:  Per Telecare note from 7/6/21, patient stated that he has rashes on his right hip and right buttock area that looks like a blister, stated he had his shingles vaccine [on 6/29/2021] and noticed the rashes on Sunday (7/4/21). After examination of rash, PCP prescribed valacyclovir and lidocaine ointment. Per Telecare note on 7/12/21, patient reports the rash is still present and burning/itching. Note states it is therefore "unclear if rash was due to zoster" and it was recommended to seek emergency care. Patient called back same day and said he would be going to a local non agency ER.
Age: 51.0
Sex: F
Vaccine: VARZOS
Symptoms: Incomplete course of vaccination, Rash, Rash pruritic, Skin discolouration
Clinical narrative: Narrative:  Patient received first dose on 2/8/21. On 2/19/21 patient sent a secure message to PCP notifying him that she had a "terrible reaction to the Shingles vaccination last week." She states she was seen at a walk-in click and was prescribed doxycycline for 7 days but her arm rash was still "spreading and itching black and blue". Left arm WNL as of 4/5/21, but patient hesitant to receive 2nd dose of vaccine. Pt declined 2nd dose on 7/6/21. As of 8/17/21, it has not be addressed by PCP whether or not the patient should receive the 2nd dose.
Age: 54.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: COVID-19, Chest discomfort, Chills, Cough, Diarrhoea
Clinical narrative: Narrative:  54 yo male patient with PMH including CAD, ptca/stent 1 yr ago, mod COPD, OSA, prev tobacco use, dyslipidemia, prostate ca s/p RALP with PLND in 2019, and GERD, who presented to the ED c/p fever, chills, headache, dry cough, wheezing, chest pressure, nausea, diarrhea, body aches since 8/8/21. Patient was noted to be positive for COVID on 8/12/2021 and was fully vaccinated with COVID vaccine Pfizer on 3/2/21 and 3/23/21.
Age: 54.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Headache, Nausea, Pain, Pyrexia, SARS-CoV-2 test positive
Clinical narrative: Narrative:  54 yo male patient with PMH including CAD, ptca/stent 1 yr ago, mod COPD, OSA, prev tobacco use, dyslipidemia, prostate ca s/p RALP with PLND in 2019, and GERD, who presented to the ED c/p fever, chills, headache, dry cough, wheezing, chest pressure, nausea, diarrhea, body aches since 8/8/21. Patient was noted to be positive for COVID on 8/12/2021 and was fully vaccinated with COVID vaccine Pfizer on 3/2/21 and 3/23/21.
Age: 54.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Wheezing
Clinical narrative: Narrative:  54 yo male patient with PMH including CAD, ptca/stent 1 yr ago, mod COPD, OSA, prev tobacco use, dyslipidemia, prostate ca s/p RALP with PLND in 2019, and GERD, who presented to the ED c/p fever, chills, headache, dry cough, wheezing, chest pressure, nausea, diarrhea, body aches since 8/8/21. Patient was noted to be positive for COVID on 8/12/2021 and was fully vaccinated with COVID vaccine Pfizer on 3/2/21 and 3/23/21.
Age: 83.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Asthenia, COVID-19, Decreased appetite, Failure to thrive, Malaise
Clinical narrative: Narrative:  83 yo male patient with well controlled DM, essential hypertension, COPD on chronic oxygen (2L with exertion and sleep), prior CVA with residual r sided weakness, suprapubic cath (last changed 8/12), OSA (noncompliant with bipap - uses 2L o2 nasal canula at night), chronic diastolic heart failure, pacemaker, permanent afib on apixaban, CAD who was brought by ambulance by wife's request for generalized failure to thrive, increased oxygen requirements (4L), and non-compliance with medications. Patient with several days of generalized weakness and decreased appetite. Upon admission, patient with CRS grade of 3, no fever but oxygen up to 10L. Patient was noted to be COVID positive on 8/16/21 with symptom onset on 8/9/21. Patient was fully vaccinated with COVID vaccine Pfizer on 1/15/21 and 2/5/21.
Age: 83.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: SARS-CoV-2 test positive, Treatment noncompliance
Clinical narrative: Narrative:  83 yo male patient with well controlled DM, essential hypertension, COPD on chronic oxygen (2L with exertion and sleep), prior CVA with residual r sided weakness, suprapubic cath (last changed 8/12), OSA (noncompliant with bipap - uses 2L o2 nasal canula at night), chronic diastolic heart failure, pacemaker, permanent afib on apixaban, CAD who was brought by ambulance by wife's request for generalized failure to thrive, increased oxygen requirements (4L), and non-compliance with medications. Patient with several days of generalized weakness and decreased appetite. Upon admission, patient with CRS grade of 3, no fever but oxygen up to 10L. Patient was noted to be COVID positive on 8/16/21 with symptom onset on 8/9/21. Patient was fully vaccinated with COVID vaccine Pfizer on 1/15/21 and 2/5/21.
Age: 79.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: COVID-19, Dyspnoea, Fatigue, SARS-CoV-2 test positive
Clinical narrative: Narrative:  Patient is a 79-year-old vaccinated (s/p 2 doses moderna) male with co-morbidities of OSA, T2DM, HTN, HLD and obesity who presents for fatigue and dyspnea with a known positive COVID-19 test from 8/9/2021. Patient is a poor historian but reports his symptoms started around the time of his positive test on 8/9. He states he did not feel short of breath but did have fatigue In the ED, intiially O2 saturation 65% on room air, was placed on HFNC FiO2 32%, now requriing 100% fio2 on hhfnc. Patient was fully vaccinated with COVID vaccine Moderna on 2/11/21 and 3/11/21.